← Open Payments lookup

LISA BEARMAN: Open Payments

NPI 1306492913 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$309 in 11 payments from 10 companies in 2025. Trend: 2023 $802 · 2024 $1,460 · 2025 $309

Food & beverage: $309
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.2$79
Axsome Therapeutics, Inc.1$34
Regeneron Healthcare Solutions, Inc.1$31
JAZZ PHARMACEUTICALS INC.1$29
Merck Sharp & Dohme LLC1$28
Radius Health, Inc.1$27
Actelion Pharmaceuticals US, Inc.1$27
Vifor Pharma, Inc.1$18
Insmed, Inc.1$18
GlaxoSmithKline, LLC.1$18

Products named: GLASSIA, Sunosi, DUPIXENT, XYWAV, KEYTRUDA, OPSUMIT, Zemaira, Arikayce.

Industry payments across MD — which companies pay providers there.